16:12 , Dec 12, 2018 |  BC Innovations  |  Distillery Therapeutics

Cardiovascular

INDICATION: Myocardial infarction (MI) Cell culture and mouse studies suggest treatment with cilnidipine or inhibiting DNM1L could help treat MI. Screening of antihypertensive drugs in primary rat cardiac fibroblasts cultured under hypoxic conditions identified that...
19:11 , May 8, 2017 |  BC Innovations  |  Distillery Therapeutics

Autoimmune disease

INDICATION: Multiple sclerosis (MS) Mouse studies suggest inhibiting the calcium channel L-type could help treat MS. In the experimental autoimmune encephalomyelitis (EAE) mouse model of MS, a calcium channel L-type inhibitor decreased MS symptom scores,...
23:08 , Jan 3, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Breast cancer; pancreatic cancer Patient sample and mouse studies suggest inhibiting CACNA1D or CACNA1S could help treat invasive breast and pancreatic cancers. In patients with invasive breast cancer, levels of CACNA1D were higher in...